CLOE SAVINO: Open Payments
NPI 1164010856 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,902 in 51 payments from 15 companies in 2025. Trend: 2023 $1,617 · 2024 $2,643 · 2025 $1,902
Food & beverage: $1,803Education: $99
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 3 | $363 |
| ABBVIE INC. | 11 | $222 |
| LEO Pharma Inc. | 7 | $217 |
| Galderma Laboratories, L.P. | 4 | $176 |
| Novartis Pharmaceuticals Corporation | 4 | $167 |
| Regeneron Healthcare Solutions, Inc. | 3 | $165 |
| UCB, Inc. | 3 | $158 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $141 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Incyte Corporation | 3 | $71 |
Products named: DUPIXENT, NEMLUVIO, SKYRIZI, Bimzelx, ANZUPGO, Winlevi, OPZELURA, ADBRY.
Industry payments across NY — which companies pay providers there.
